Intrinsiqq
West Pharmaceutical Services, Inc. logo

West Pharmaceutical Services, Inc.

WST

Compare

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$27.85B
EPS$8.91
P/E44.87
P/FCF61.43
EV/EBITDA28.72
FCF Yield1.6%
Div. Yield0.23%
Net Debt/FCF-0.3x
West Pharmaceutical Services, Inc. intrinsic value
52-Week Range
$230.95$416.67

Profitability & Returns

Revenue (TTM)

$3.40B

▲ +6.3% YoY

Net Income (TTM)

$639M

▲ +0.2% YoY

Op. Margin

22.97%

▼ -0.7pp YoY

ROIC

18.27%

▼ -0.7pp YoY

Cash Flow & Balance Sheet

FCF (TTM)

$453M

▲ +69.6% YoY

Op. Cash Flow (TTM)

$655M

▲ +15.5% YoY

Net Debt

-$150M

Net Cash Position

Cash & Equiv.

$464M

5Y CAGR: +7.4%

5Y CAGR: +9.5%

Continue Research

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with WST

CompareIntrinsic value
GMEDGlobus Medical Inc.
$71.05-12.76%72
MMEDMiniMed Group, Inc.
$16.71-7.98%25
PODDInsulet Corporation
$145.30-6.93%79
TFXTeleflex Incorporated
$150.87-0.84%31
ICUIIcu Medical Inc.
$172.11+2.66%46
DXCMDexCom, Inc.
$79.41-5.98%88
IARTIntegra LifeSciences Holdings Corporation
$13.42-4.96%28
MMSIMerit Medical Systems, Inc.
$87.23-2.67%61

Held by ETFs

WST is in 257 US ETFs. The largest of them, with WST's weight in each:

West Pharmaceutical Services (WST) in four numbers

Fair value (earnings)
$250.32
Price $399.81 is 60% above it.
Intrinsic Value
Quality score
46/100
Best check: share count change, -6.6%. Weakest: margin trend, -2.5pp.
Quality
Dividend (TTM)
$0.88
0.23% yield, raised 13 years in a row.
Dividends
P/E
44.87
Price to free cash flow 61.43.
Financials

Questions about West Pharmaceutical Services

Is West Pharmaceutical Services (WST) overvalued?

At $399.81, West Pharmaceutical Services' price is 60% above the $250.32 a share fair value that Intrinsiqq's calculator gets from its earnings. It trades at 44.87 times earnings and 61.43 times free cash flow. The growth behind that figure is yours to set on the Intrinsic Value tab. See how to tell if a stock is overvalued.

What is West Pharmaceutical Services' fair value?

Intrinsiqq's calculator puts West Pharmaceutical Services' fair value at $250.32 a share. It grows earnings per share 8.2% a year for 5 years, applies an exit P/E of 30, and works back at a 10% yearly return. A 25% margin of safety gives a buy-below price of $187.74. Every input can be changed on the Intrinsic Value tab.

Is West Pharmaceutical Services a high-quality business?

West Pharmaceutical Services scores 46 out of 100 on Intrinsiqq's quality score, which makes it a mixed business on these measures. The score blends 8 checks computed from SEC filings. Its best check is share count change at -6.6%, and its weakest is margin trend at -2.5pp. The Quality tab shows every check against its target.

Does West Pharmaceutical Services (WST) pay a dividend, and how much?

Yes. West Pharmaceutical Services (WST) pays a dividend: $0.88 per share over the last twelve months, a dividend yield of 0.23% at the latest close. It has raised its dividend per share for 13 years in a row, growing at 5.4% a year over the last 5 years. The payout takes about 9.8% of earnings.

Source: 10-Q filed 21 Oct 2026 (period ending 30 Sept 2026), SEC. Price: last close 6 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in WST's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing WST

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.